Application of oyster polysaccharide in prevention and treatment of ischemia-reperfusion injury
By using oyster polysaccharides as the active ingredient, products for the prevention and treatment of myocardial ischemia-reperfusion injury were prepared, which solved the problem of insufficient regulation of myocardial ischemia-reperfusion injury in existing technologies, achieved significant prevention and treatment effects, and provided a brand-new natural drug option.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA AGRI UNIV
- Filing Date
- 2026-06-15
- Publication Date
- 2026-07-17
AI Technical Summary
Current technology has not fully elucidated the regulatory effect of oyster polysaccharides on myocardial ischemia-reperfusion injury. Ischemia-reperfusion injury is a key bottleneck in cardiac pathological remodeling and heart failure, and early intervention is needed to regulate inflammation and oxidative stress.
Products for the prevention and treatment of myocardial ischemia-reperfusion injury are prepared using oyster polysaccharides as the sole active ingredient. These products include improving cardiac function, reducing myocardial cell damage, and protecting mitochondrial structure and energy metabolism. The products are administered via oral or injection routes.
It significantly improves cardiac structural and functional damage, reverses cardiac dysfunction, reduces myocardial infarction area, regulates oxidative stress, and enhances myocardial energy metabolism, providing a novel natural drug candidate for the prevention and treatment of cardiac ischemia-reperfusion injury.
Smart Images
Figure CN122398849A_ABST